Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil with glycopyrrolate or trospium in elderly healthy volunteers
NL-OMON45462Active, not recruiting
- Sponsor
- Sio Gene Therapies
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of donepezil, glycopyrronium and trospium in Alzheimer's disease (AD) and Dementia (4 arms), sponsored by Sio Gene Therapies. Primary endpoints: Single-dose safety and tolerability of donepezil with placebo, glycopyrrolate, or trospium, Multiple-dose safety and tolerability of donepezil with placebo, glycopyrrolate, or trospium and 2 more. Started Nov 2016; status: active, not recruiting.
02
Drugs
donepezilglycopyrroniumtrospium
03
Conditions
Alzheimer's disease (AD)Dementia
Beyond the preview
Go deeper on NL-OMON45462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45462.